Delivery Order SPE2DB24D1201-SPE2DB26FJADC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,073.16 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,621.17 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This competitively awarded, firm fixed-price delivery order is set to be completed by August 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $37,143.21 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml configurations. The contract was competitively awarded without set-aside designation and is scheduled for completion by June 10, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a $15,411.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pen 3ml formulations. The contract was competitively awarded without a set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the company's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $19,789.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL format. The contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside competitive award and is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,455.97 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. This is a firm fixed price, non-competitive set-aside contract with an ultimate completion date of June 2, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,095.18 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml volumes. This firm fixed-price delivery order, issued on June 30, 2025, with completion targeted for July 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract carries no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $2,506.64 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml quantities. This firm fixed price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-competitive procurement under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is listed as AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $18,198.96 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. The contract was competitively awarded with firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulations, with a ceiling value of $8,761.83. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.9 billion through December 2026. The award was made through competitive procedures with no set-aside...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB26FJADCDelivery Order
The Defense Logistics Agency awarded a $11,296.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with an ultimate completion date of October 16, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical supply will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for the federal medical supply chain, particularly supporting military and veteran healthcare systems through the Defense Health Agency and related government healthcare programs. The company's extensive contract portfolio with DLA demonstrates its capability to deliver a comprehensive range of pharmaceutical products across multiple therapeutic domains on a competitive basis. This delivery order for Ozempic reflects the ongoing demand for specialty diabetes medications within the military healthcare system and exemplifies AmerisourceBergen's role in supporting the Department of Defense's pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.3k | 10/15/25 |